Operating Lease, Right-of-Use Asset of NewAmsterdam Pharma Co N.V. from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NewAmsterdam Pharma Co N.V. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • NewAmsterdam Pharma Co N.V. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $185,000, a 57% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NewAmsterdam Pharma Co N.V. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $185,000 -$246,000 -57% 31 Dec 2025 10-K 18 Feb 2026 2025 FY
Q3 2025 $246,000 -$247,000 -50% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $308,000 -$246,000 -44% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 $369,000 +$331,000 +871% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $431,000 +$376,000 +684% 31 Dec 2024 10-K 18 Feb 2026 2025 FY
Q3 2024 $493,000 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $554,000 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $38,000 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $55,000 -$65,000 -54% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q4 2022 $120,000 31 Dec 2022 10-K 28 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.